Spatial Concept – Page 12

FDA Approves Roche’s Tecentriq Hybreza: First Subcutaneous PD-L1 Cancer Immunotherapy

1 year ago talkbio0Tagged Approved, atezolizumab, Enhanze drug delivery technology, Hyaluronidase-tqjs, Hybreza, Immunotherapy for cancer, Inhibitor, PD-L1, Roche (company), subcutaneous, Tecentriq, United States Food and Drug Administration

Tecentriq Hybreza, Subcutaneous PD-L1 inhibitor, Cancer immunotherapy, FDA approval, Roche, Atezolizumab, Hyaluronidase-tqjs, Enhanze drug delivery technology

Triple Threat: 50% of Women Delay or Skip Medical Care Due to Affordability, Access, and Negative Experiences

1 year ago talkbio0Tagged Access, Affordability, barriers, Delayed medical care, disparities, Experience, Gender, Health care facility, Healthcare equity, issues, Negative, Women 's healthcare

Women’s healthcare, Delayed medical care, Affordability issues, Access barriers, Negative healthcare experiences, Gender disparities in healthcare, Healthcare equity

Moderna’s Mpox Vaccine Shows Superior Efficacy in Preclinical Study Compared to Approved Version

1 year ago talkbio0Tagged Approved version, Effectiveness, Moderna, mpox vaccine, Preclinical Study, Upper

Moderna, Mpox vaccine, Preclinical study, Superior efficacy, Approved version

The Post-Chevron Regulatory Landscape: Implications for the FDA and Healthcare Industry

1 year ago talkbio0Tagged Administrative procedure, Boards (medical device), Chevron Deference, Corner Post, court, Federal Reserve System, Governors, Healthcare Industry, judicial, Landscapes, Legal, Loper Bright Enterprises, Raimondo, regulatory, Supreme, United States Food and Drug Administration

Chevron deference, FDA, regulatory landscape, healthcare industry, Supreme Court ruling, Loper Bright Enterprises v. Raimondo, Corner Post, Inc. v. Board of Governors of the Federal Reserve System, Administrative Procedure Act (APA), judicial scrutiny, legal challenges, regulatory implications.

Embracing Agility: Critical for the Role of QARA Professional

1 year ago talkbio0Tagged Access, Agility, AI, Artificial Intelligence, Communication, Diversity, Inclusion, Leadership, Market, professional occupation status, QARA, quality assurance, Regulatory Affairs, regulatory strategy, Technology

QARA Professional, Agility, Quality Assurance, Regulatory Affairs, Market Access, Innovative Therapeutic Solutions, AI, Technology, Regulatory Strategy, Leadership, Communication, Diversity, Inclusion.

Mallinckrodt to Sell Therakos Business Unit to CVC Capital for $925 Million

1 year ago talkbio0Tagged Capital Partners, central venous catheter (CVC) sets, Extracorporeal, Healthcare services, Immunotherapy, Lymphoma, T-Cell, Cutaneous, mallinckrodt, medical technology, Photopheresis, RNASE3 gene, Therakos

Mallinckrodt, Therakos, CVC Capital Partners, photopheresis, extracorporeal photopheresis, ECP, cutaneous T-cell lymphoma, CTCL, immunotherapy, pharmaceuticals, medical technology, healthcare services